Want to see ALGN full AI Analyst Report?

Align Tech (ALGN) Stock Forecast & Price Target

3,367 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALGN Analyst Ratings

Moderate Buy

8 Buy

3 Hold

1 Sell

Based on 12 analysts giving stock ratings to

Align

Tech

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALGN Stock 12 Month Forecast

Average Price Target

$208.00

▲(9.43% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Align Tech in the last 3 months. The average price target is $208.00 with a high forecast of $240.00 and a low forecast of $175.00. The average price target represents a 9.43% change from the last price of $190.07.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"126":"$126","241":"$241","154.75":"$154.8","183.5":"$183.5","212.25":"$212.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$240.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":208,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$208.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$175.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[126,154.75,183.5,212.25,241],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,175.1723076923077,180.57461538461538,185.97692307692307,191.3792307692308,196.78153846153847,202.18384615384616,207.58615384615385,212.98846153846154,218.39076923076925,223.7930769230769,229.19538461538463,234.5976923076923,{"y":240,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,172.71076923076924,175.65153846153848,178.5923076923077,181.53307692307692,184.47384615384615,187.4146153846154,190.35538461538462,193.29615384615386,196.2369230769231,199.17769230769233,202.11846153846153,205.05923076923077,{"y":208,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.77,170.1723076923077,170.57461538461538,170.97692307692307,171.3792307692308,171.78153846153847,172.18384615384616,172.58615384615385,172.98846153846154,173.39076923076922,173.79307692307694,174.19538461538463,174.5976923076923,{"y":175,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":178.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.52,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.88,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.72,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.63,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":189.02,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.73,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.91,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.77,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$240.00

Average Price Target$208.00

Lowest Price Target$175.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jason Bednar

Piper Sandler

$235

Buy

23.64%

Upside

Reiterated

06/18/26

Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)

Glen Santangelo

Barclays

$200

Buy

5.22%

Upside

Reiterated

06/04/26

Analysts' Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Align Tech (NASDAQ: ALGN) and AMN Healthcare Services (NYSE: AMN)

Erin Wright

Morgan Stanley

$188

Hold

-1.09%

Downside

Reiterated

05/28/26

Align Technology Price Target Maintained at $188 as Erin Wright Reiterates Hold on Balanced Upside and Execution Risks

Daniel Grosslight

Citi

$240

Buy

26.27%

Upside

Reiterated

05/28/26

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Apogee Therapeutics (NASDAQ: APGE) and Align Tech (NASDAQ: ALGN)

Michael Cherny

Leerink Partners

$230

Buy

21.01%

Upside

Reiterated

05/27/26

Leerink sees numerous ways for Align to drive multi-year upsideLeerink sees numerous ways for Align to drive multi-year upside

Michael Ryskin

Bank of America Securities

$175

Sell

-7.93%

Downside

Reiterated

05/27/26

Align Technology: Sell Rating Reiterated as Macro Headwinds Temper Near-Term Outlook; $175 Price Target Maintained

Jonathan Block

Stifel Nicolaus

$210

Buy

10.49%

Upside

Reiterated

05/25/26

Align Tech (ALGN) Gets a Buy from Stifel Nicolaus

Elizabeth Anderson CFA

Evercore ISI

$220

Buy

15.75%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)

Kevin Caliendo

UBS

$185→$186

Hold

-2.14%

Downside

Reiterated

05/01/26

UBS Reaffirms Their Hold Rating on Align Tech (ALGN)

Steven Valiquette

Mizuho Securities

$215→$220

Buy

15.75%

Upside

Reiterated

04/30/26

Align Tech (ALGN) Gets a Buy from Mizuho Securities

David Saxon

Needham

$185→$184

Hold

-3.19%

Downside

Reiterated

04/30/26

Align Technology Kept at Hold as Higher Gas Prices Offset Tax Refund Tailwind for Clear Aligners

Sidharth Sahoo

HSBC

$150→$200

Buy

5.22%

Upside

Upgraded

02/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Jeff Johnson

Robert W. Baird

$205→$218

Buy

14.69%

Upside

Reiterated

02/05/26

Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird

Vik Chopra

Wells Fargo

$181→$200

Buy

5.22%

Upside

Reiterated

02/05/26

Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jason Bednar

Piper Sandler

$235

Buy

23.64%

Upside

Reiterated

06/18/26

Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)

Glen Santangelo

Barclays

$200

Buy

5.22%

Upside

Reiterated

06/04/26

Analysts' Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Align Tech (NASDAQ: ALGN) and AMN Healthcare Services (NYSE: AMN)

Erin Wright

Morgan Stanley

$188

Hold

-1.09%

Downside

Reiterated

05/28/26

Align Technology Price Target Maintained at $188 as Erin Wright Reiterates Hold on Balanced Upside and Execution Risks

Daniel Grosslight

Citi

$240

Buy

26.27%

Upside

Reiterated

05/28/26

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Apogee Therapeutics (NASDAQ: APGE) and Align Tech (NASDAQ: ALGN)

Michael Cherny

Leerink Partners

$230

Buy

21.01%

Upside

Reiterated

05/27/26

Leerink sees numerous ways for Align to drive multi-year upsideLeerink sees numerous ways for Align to drive multi-year upside

Michael Ryskin

Bank of America Securities

$175

Sell

-7.93%

Downside

Reiterated

05/27/26

Align Technology: Sell Rating Reiterated as Macro Headwinds Temper Near-Term Outlook; $175 Price Target Maintained

Jonathan Block

Stifel Nicolaus

$210

Buy

10.49%

Upside

Reiterated

05/25/26

Align Tech (ALGN) Gets a Buy from Stifel Nicolaus

Elizabeth Anderson CFA

Evercore ISI

$220

Buy

15.75%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)

Kevin Caliendo

UBS

$185→$186

Hold

-2.14%

Downside

Reiterated

05/01/26

UBS Reaffirms Their Hold Rating on Align Tech (ALGN)

Steven Valiquette

Mizuho Securities

$215→$220

Buy

15.75%

Upside

Reiterated

04/30/26

Align Tech (ALGN) Gets a Buy from Mizuho Securities

David Saxon

Needham

$185→$184

Hold

-3.19%

Downside

Reiterated

04/30/26

Align Technology Kept at Hold as Higher Gas Prices Offset Tax Refund Tailwind for Clear Aligners

Sidharth Sahoo

HSBC

$150→$200

Buy

5.22%

Upside

Upgraded

02/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Jeff Johnson

Robert W. Baird

$205→$218

Buy

14.69%

Upside

Reiterated

02/05/26

Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird

Vik Chopra

Wells Fargo

$181→$200

Buy

5.22%

Upside

Reiterated

02/05/26

Wells Fargo Keeps Their Buy Rating on Align Tech (ALGN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Align Tech

3 Months

Steven ValiquetteMizuho Securities

Success Rate

13/22 ratings generated profit

Average Return

+10.98%

Copying Steven Valiquette's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +10.98% per trade.

1 Year

Michael RyskinBank of America Securities

Success Rate

14/22 ratings generated profit

Average Return

+0.15%

Copying Michael Ryskin's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +0.15% per trade.

2 Years

Michael RyskinBank of America Securities

Success Rate

15/22 ratings generated profit

Average Return

+18.04%

Copying Michael Ryskin's trades and holding each position for 2 Years would result in 68.18% of your transactions generating a profit, with an average return of +18.04% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALGN Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALGN has received 20 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. ALGN average Analyst price target in the past 3 months is 208.00.

Each month's total comprises the sum of three months' worth of ratings.

ALGN Financial Forecast

ALGN Earnings Forecast

Next quarter’s earnings estimate for ALGN is $2.63 with a range of $2.51 to $2.98. The previous quarter’s EPS was $2.58. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Sales Forecast

Next quarter’s sales forecast for ALGN is $1.06B with a range of $1.05B to $1.10B. The previous quarter’s sales results were $1.04B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Stock Forecast FAQ

What is ALGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Align Technology’s 12-month average price target is 208.00.

What is ALGN’s upside potential, based on the analysts’ average price target?

Align Technology has 9.43% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALGN a Buy, Sell or Hold?

Align Technology has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 1 sell ratings.

What is Align Technology’s price target?

The average price target for Align Technology is 208.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $240.00 ,the lowest forecast is $175.00. The average price target represents 9.43% Increase from the current price of $190.07.

What do analysts say about Align Technology?

Align Technology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of ALGN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Align Tech (ALGN) Stock Forecast & Price Target

ALGN Analyst Ratings

ALGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Align Tech

ALGN Analyst Recommendation Trends

ALGN Financial Forecast

ALGN Earnings Forecast

ALGN Sales Forecast

ALGN Stock Forecast FAQ

Detailed List of Analyst Forecasts